Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Nomura Holdings ( (NMR) ) is now available.
On June 23, 2025, Nomura Holdings released its financial report detailing the company’s capitalization and indebtedness as of March 31, 2025. The report highlighted that there has been no significant change in the company’s financial structure since that date, with total capitalization and indebtedness amounting to ¥18,071,969 million. This financial stability is crucial for stakeholders as it reflects Nomura’s robust position in the financial industry, ensuring continued confidence in its operations and market strategy.
Spark’s Take on NMR Stock
According to Spark, TipRanks’ AI Analyst, NMR is a Neutral.
Nomura Holdings demonstrates strong growth and operational efficiency with a robust revenue increase and high EBIT margin. However, financial risks from high leverage and negative cash flow, coupled with technical indicators showing potential bearish trends, balance the positive valuation metrics and strategic initiatives from the earnings call. The stock’s low P/E ratio and healthy dividend yield make it attractive for value investors, but caution is advised due to financial and market volatility.
To see Spark’s full report on NMR stock, click here.
More about Nomura Holdings
Nomura Holdings, Inc. is a prominent financial services group based in Tokyo, Japan. It operates in the investment banking industry, offering a wide range of services including asset management, retail brokerage, and wholesale operations. The company is known for its global reach and significant presence in the financial markets.
Average Trading Volume: 801,276
Technical Sentiment Signal: Strong Buy
Current Market Cap: $18.05B
See more insights into NMR stock on TipRanks’ Stock Analysis page.